Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir. Pickering RT, Asundi A, Olson A, Soden K, et al. Antivir Ther 2025;30:13596535251314571.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pickering RT, Asundi A, Olson A, Soden K, et al. Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir. Antivir Ther 2025;30:13596535251314571.
PMID: 39953931